Q BioMed Inc.

Common Stock SEC Reporting - Current
Contact Info
  • 501 Madison Ave
  • 14th Floor
  • New York, NY 10022

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Aug 31, 2016 10-Q
CIK 0001596062
Fiscal Year End 11/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2014
Employees 1 a/o Nov 30, 2014
Company Officers/Contacts
Denis Corin President, Consultant
Ari Jatwes Business Analyst
Company Directors
Denis Corin
William Rosenstadt
Company Notes
  • Formerly=ISMO Tech Solutions, Inc. until 7-2015
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

Legal Counsel
Sanders Ortoli Vaughn-Flam Rosenstadt LLP
501 Madison Avenue
14th Floor
New York, NY, 10022
United States

Investor Relations Firm
Not Available
QBIO Security Details
Share Structure
Market Value1 $33,790,100 a/o Dec 02, 2016
Authorized Shares 250,000,000 a/o Nov 30, 2016
Outstanding Shares 9,167,146 a/o Nov 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 4,999,835 a/o May 06, 2016
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 375 a/o May 06, 2016
Short Selling Data
Short Interest 82,463 (11.09%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security